StockMacro
Menu

Eledon Pharmaceuticals

$1.78 -54% in 6 monthsMarket cap $150.3M

ELDN on XNAS, Health Care, Eledon Pharmaceuticals, Inc., job postings

Measures activity, not value. Not investment advice.

Net loss of $85M over 12 months with $69.7M cash, but shares are up 28% in a year.

  • BadShort interest 9.8% of shares, up 4.5% on the prior report

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Industry
Pharmaceutical preparations (Health Care)
Employees
33
Website
eledon.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 18 Mar 2027 (an estimate: a year ago it reported on 19 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $3.9M.
Quarter to 31 Dec 2021: revenue –, net income -$8.8MQuarter to 31 Mar 2022: revenue –, net income -$9.9MQuarter to 30 Jun 2022: revenue –, net income -$9.2MQuarter to 30 Sep 2022: revenue –, net income -$10.5MQuarter to 31 Dec 2022: revenue –, net income -$58.4MQuarter to 31 Mar 2023: revenue –, net income -$10.8MQuarter to 30 Jun 2023: revenue –, net income -$9.6MQuarter to 30 Sep 2023: revenue –, net income -$10.3MQuarter to 31 Dec 2023: revenue –, net income -$9.6MQuarter to 31 Mar 2024: revenue –, net income -$10.3MQuarter to 30 Jun 2024: revenue –, net income -$44.9MQuarter to 30 Sep 2024: revenue –, net income $77.0MQuarter to 31 Mar 2025: revenue –, net income -$6.5MQuarter to 30 Jun 2025: revenue –, net income -$11.2MQuarter to 30 Sep 2025: revenue –, net income -$17.5MQuarter to 31 Dec 2025: revenue –, net income -$10.4MQuarter to 31 Mar 2026: revenue –, net income -$39.0MQuarter to 30 Jun 2026: revenue –, net income -$31.6MQuarter to 30 Sep 2026: revenue –, net income -$3.9M
31 Dec 2021RevenueNet incomeNet losstallest bar $77.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$3.9M
30 Jun 2026–-$31.6M
31 Mar 2026–-$39.0M
31 Dec 2025–-$10.4M
30 Sep 2025–-$17.5M
30 Jun 2025–-$11.2M
31 Mar 2025–-$6.5M
30 Sep 2024–$77.0M
30 Jun 2024–-$44.9M
31 Mar 2024–-$10.3M
31 Dec 2023–-$9.6M
30 Sep 2023–-$10.3M
30 Jun 2023–-$9.6M
31 Mar 2023–-$10.8M
31 Dec 2022–-$58.4M
30 Sep 2022–-$10.5M
30 Jun 2022–-$9.2M
31 Mar 2022–-$9.9M
31 Dec 2021–-$8.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$85.0M -$79.8M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.73 $0.77
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -257% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $69.7M $93.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$69.7M (net cash) -$93.4M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.36
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 4.9 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Eledon PharmaceuticalsELDN (this company) $150.3Mloss–––
Atrium TherapeuticsRNA $149.3M––––
Oramed PharmaceuticalsORMP $155.2M––––
BridgeBio Oncology TherapeuticsBBOT $145.3Mloss–––
ALX OncologyALXO $137.0Mloss–––
Abeona TherapeuticsABEO $165.3Mloss3.5–-160%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-3.2%

153 13F filers vs 158

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

54%

45.5M shares held by 13F filers (30 Sep 2026) of 84.5M outstanding (10 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

9.8%

8.3M shares sold short (30 Oct 2026) of 84.5M outstanding (10 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

7.5

8.3M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+4.5%

7.9M shares sold short in the report before, 8.3M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

70%

70% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 55%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

3

3 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

3.0×

3 articles in the last 7 days; its usual week has 1.

Price $1.78 on 20 Nov 2026, +28% over 12 months (12-month range $1.39 to $4.21)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $0).
Institutional holders (13F filers). 153 13F filers reported holding it in the latest 13F quarter, +84% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
2 Dec 2025Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.5M (2025-11-14); 6.8x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 4.3M vs usual 1.5M (2025-10-31); 4.5x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 6.7M vs usual 1.4M (2025-09-30); 56.4x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 5.4M vs usual 1.3M (2025-09-15); 65.2x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 4.3M vs usual 1.3M (2025-08-29); 36.8x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 5.5M vs usual 1.2M (2025-08-15); 54.2x the same period a year earlier
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 27 vs usual 4 (2025-06-30); 3.9x the same period a year earlier
14 Aug 20258-K and other filingsEarlier financial statements can no longer be relied on
12 Aug 2025Sharp changeShort interest spike: short interest spike, 4.4M vs usual 1.2M (2025-07-31); 40.5x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 3.1M vs usual 1.1M (2025-07-15); 24.1x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 1.8M vs usual 181K (2025-04-15); 56.3x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 1.5M vs usual 157K (2025-03-31); 13.7x the same period a year earlier
7 Apr 20258-K and other filingsChanged its auditor
1 Apr 2025Sharp changeShort interest spike: short interest spike, 1.4M vs usual 136K (2025-03-14); 37.8x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 1.3M vs usual 124K (2025-02-28); 34.5x the same period a year earlier
4 Mar 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 118K (2025-02-14); 22.1x the same period a year earlier
18 Feb 2025Sharp changeMany funds opening a new position: many funds opening a new position, 34 vs usual 3.50 (2024-12-31); 8.5x the same period a year earlier
18 Feb 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 113K (2025-01-31); 20.1x the same period a year earlier
28 Jan 2025Sharp changeShort interest spike: short interest spike, 1.0M vs usual 107K (2025-01-15); 14.0x the same period a year earlier
14 Jan 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 104K (2024-12-31); 24.0x the same period a year earlier
31 Dec 2024Sharp changeShort interest spike: short interest spike, 898K vs usual 92K (2024-12-13); 13.8x the same period a year earlier
20 Dec 20248-K and other filingsDirector or officer change
20 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Dec 2024Sharp changeShort interest spike: short interest spike, 687K vs usual 77K (2024-11-29); 26.1x the same period a year earlier
3 Dec 2024Sharp changeShort interest spike: short interest spike, 731K vs usual 69K (2024-11-15); 11.1x the same period a year earlier
19 Nov 2024Sharp changeShort interest spike: short interest spike, 961K vs usual 66K (2024-10-31); 18.3x the same period a year earlier
14 Aug 20248-K and other filingsEarlier financial statements can no longer be relied on
14 Aug 20248-K and other filingsReport will be filed late
12 Jul 20248-K and other filingsChanged its auditor
10 Jul 20248-K and other filingsDirector or officer change
10 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 May 20248-K and other filingsPrivate placement of securities (Form D)
2 Oct 20238-K and other filingsDirector or officer change
20 Sep 20238-K and other filingsDirector or officer change
13 Sep 20238-K and other filingsDirector or officer change
21 Jun 20238-K and other filingsDirector or officer change
22 May 20238-K and other filingsPrivate placement of securities (Form D)
1 May 20238-K and other filingsDirector or officer change
1 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: $9K published
Month from 1 Nov 2022: $3K published
Month from 1 May 2023: $0 published
Month from 1 May 2024: $0 published
Institutional holders (13F filers)
31 Dec 2021 report: 36; public on 14 Feb 2022
31 Mar 2022 report: 31; public on 16 May 2022
30 Jun 2022 report: 30; public on 15 Aug 2022
30 Sep 2022 report: 29; public on 14 Nov 2022
31 Dec 2022 report: 26; public on 14 Feb 2023
31 Mar 2023 report: 29; public on 15 May 2023
30 Jun 2023 report: 32; public on 14 Aug 2023
30 Sep 2023 report: 27; public on 14 Nov 2023
31 Dec 2023 report: 28; public on 14 Feb 2024
31 Mar 2024 report: 29; public on 15 May 2024
30 Jun 2024 report: 31; public on 14 Aug 2024
30 Sep 2024 report: 33; public on 14 Nov 2024
31 Dec 2024 report: 73; public on 14 Feb 2025
31 Mar 2025 report: 82; public on 15 May 2025
30 Jun 2025 report: 83; public on 14 Aug 2025
30 Sep 2025 report: 83; public on 14 Nov 2025
31 Dec 2025 report: 87; public on 17 Feb 2026
31 Mar 2026 report: 115; public on 15 May 2026
30 Jun 2026 report: 158; public on 14 Aug 2026
30 Sep 2026 report: 153; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F funds cutting shares at 42 (30 Sep 2026), 3.7× its normal reading; higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: $0).
  • Institutional holders (13F filers): 153 13F filers reported holding it in the latest 13F quarter, +84% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 22 insider trades

No trades in the last 90 days; the latest was filed 13 May 2024. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 May 2024BVF Inc and 9 others10% ownerBuy1,927,937Not filedNot filedForm 4
9 May 2023Biotechnology Value Trading Fund OS LP and 9 othersSee Explanation of ResponsesBuy1,978,932Not filedNot filedForm 4
23 Nov 2022Steven PerrinPresidentBuy1,000$2.60$3KForm 4
21 Dec 2021David-Alexandre C GrosChief Executive OfficerBuy2,000$4.48$9KForm 4
19 Aug 2021David-Alexandre C GrosChief Executive OfficerBuy4,000$6.21$25KForm 4
14 Jun 2021Paul Sean LittleCHIEF FINANCIAL OFFICERBuy10,000$8.87$89KForm 4
10 Jun 2021David-Alexandre C GrosChief Executive OfficerBuy3,000$8.01$24KForm 4
4 Dec 2020OrbiMed Israel GP Ltd. and 1 other10% ownerSell103,200$21.60$2.2MForm 4

153 institutions reported shares at the end of Q3 2026, 54% of the shares outstanding; 17 opened a position, 24 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.6.6M7.86%$16.8M+1.5M+30%
BVF Inc6.3M7.45%$15.9MNo change
Defilade Capital Management, L.P.3.5M4.17%$8.9MNo change
Vanguard Capital Management LLC3.4M4.05%$8.6MNo change
Goldman Sachs Group Inc2.6M3.03%$6.5M+51K+2.0%
Geode Capital Management, LLC2.0M2.35%$5.0M+24K+1.2%
Ensign Peak Advisors, Inc1.8M2.08%$4.4M-345K-16%
Catalio Capital Management, LP1.6M1.94%$4.1M-58K-3.4%
State Street Corp1.6M1.91%$4.1M-7,071-0.4%
Sphera Funds Management Ltd.1.4M1.65%$3.5M+201K+17%

Company events

All 57 company events

Nothing in 12 months; the latest was filed 12 Nov 2025. Results releases and routine reports are left out.

FiledWhat happenedSource
12 Nov 2025Signed a major agreement8-K
14 Aug 2025Earlier financial statements can no longer be relied on8-K
7 Apr 2025Changed its auditor8-K
20 Dec 2024Director or officer change8-K
29 Oct 2024Signed a major agreement8-K
20 Sep 2024Signed a major agreement8-K
14 Aug 2024Quarterly report will be filed lateNT 10-Q
14 Aug 2024Earlier financial statements can no longer be relied on8-K

The 5 newest of 83 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Aug 2025confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Eledon Pharmaceuticals (ELDN): saw 27 13F filers open a new position in the quarter ended 30 Jun 2025, 3.9× the same quarter last year, while it had 6.7M shares sold short in the 30 Sep 2025 report, 56× the same report last year. Two unrelated kinds of activity within 77 days.

  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
  • Short interest and volume: Short interest spike, became public on 11 Sep 2025
  • Short interest and volume: Short interest spike, became public on 25 Sep 2025
  • Short interest and volume: Short interest spike, became public on 10 Oct 2025
2023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 342025-03-31: 182025-06-30: 27
The quarter ended 30 Jun 2025 against the 8 quarters before it. this quarterearliernormal: 4
See the evidence (7 changes)

Short interest and volume: Short interest spike became public on 25 Jul 2025

Eledon Pharmaceuticals had 3.1M shares sold short in the 15 Jul 2025 report, 24× the same report last year.

This period
3.1M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
387K
How far from its usual level
+3.5
Same report last year
129K
History used
1,642 days
2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M
the 15 Jul 2025 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

Eledon Pharmaceuticals had 4.4M shares sold short in the 31 Jul 2025 report, 40× the same report last year.

This period
4.4M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
418K
How far from its usual level
+5.1
Same report last year
108K
History used
1,658 days
2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M
the 31 Jul 2025 report24 earlier reportsnormal: 1.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

Eledon Pharmaceuticals saw 27 13F filers open a new position in the quarter ended 30 Jun 2025, 3.9× the same quarter last year.

This period
27 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
4
Typical spread (median absolute deviation)
1.5
How far from its usual level
+7.7
Same quarter last year
7
History used
1,642 days
2023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 342025-03-31: 182025-06-30: 27
the quarter ended 30 Jun 20258 earlier quartersnormal: 4

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Aug 2025

Eledon Pharmaceuticals had 5.5M shares sold short in the 15 Aug 2025 report, 54× the same report last year.

This period
5.5M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
418K
How far from its usual level
+6.8
Same report last year
101K
History used
1,673 days
2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M
the 15 Aug 2025 report24 earlier reportsnormal: 1.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Sep 2025

Eledon Pharmaceuticals had 4.3M shares sold short in the 29 Aug 2025 report, 37× the same report last year.

This period
4.3M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
428K
How far from its usual level
+4.8
Same report last year
118K
History used
1,687 days
2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M
the 29 Aug 2025 report24 earlier reportsnormal: 1.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2025

Eledon Pharmaceuticals had 5.4M shares sold short in the 15 Sep 2025 report, 65× the same report last year.

This period
5.4M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
428K
How far from its usual level
+6.5
Same report last year
83K
History used
1,704 days
2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M
the 15 Sep 2025 report24 earlier reportsnormal: 1.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Oct 2025

Eledon Pharmaceuticals had 6.7M shares sold short in the 30 Sep 2025 report, 56× the same report last year.

This period
6.7M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
1.4M
Typical spread (median absolute deviation)
413K
How far from its usual level
+8.7
Same report last year
119K
History used
1,719 days
2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M2025-09-30: 6.7M
the 30 Sep 2025 report24 earlier reportsnormal: 1.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

18 Feb 2025confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Eledon Pharmaceuticals (ELDN): saw 34 13F filers open a new position in the quarter ended 31 Dec 2024, 8.5× the same quarter last year, while it had 1.4M shares sold short in the 14 Mar 2025 report, 38× the same report last year. Two unrelated kinds of activity within 91 days.

  • Short interest and volume: Short interest spike, became public on 28 Jan 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Feb 2025
  • Short interest and volume: Short interest spike, became public on 12 Feb 2025
  • Short interest and volume: Short interest spike, became public on 27 Feb 2025
  • Short interest and volume: Short interest spike, became public on 12 Mar 2025
  • Short interest and volume: Short interest spike, became public on 26 Mar 2025
  • Short interest and volume: Short interest spike, became public on 10 Apr 2025
  • Short interest and volume: Short interest spike, became public on 26 Apr 2025
2022-12-31: 12023-03-31: 72023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 34
The quarter ended 31 Dec 2024 against the 8 quarters before it. this quarterearliernormal: 3.5
See the evidence (8 changes)

Short interest and volume: Short interest spike became public on 28 Jan 2025

Eledon Pharmaceuticals had 1.0M shares sold short in the 15 Jan 2025 report, 14× the same report last year.

This period
1.0M (the 15 Jan 2025 report)
Normal report (median of 24 earlier)
107K
Typical spread (median absolute deviation)
57K
How far from its usual level
+10.6
Same report last year
71K
History used
1,461 days
2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M
the 15 Jan 2025 report24 earlier reportsnormal: 107K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Feb 2025

Eledon Pharmaceuticals saw 34 13F filers open a new position in the quarter ended 31 Dec 2024, 8.5× the same quarter last year.

This period
34 (the quarter ended 31 Dec 2024)
Normal quarter (median of 8 earlier)
3.5
Typical spread (median absolute deviation)
1
How far from its usual level
+10.2
Same quarter last year
4
History used
1,461 days
2022-12-31: 12023-03-31: 72023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 34
the quarter ended 31 Dec 20248 earlier quartersnormal: 3.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 12 Feb 2025

Eledon Pharmaceuticals had 1.2M shares sold short in the 31 Jan 2025 report, 20× the same report last year.

This period
1.2M (the 31 Jan 2025 report)
Normal report (median of 24 earlier)
113K
Typical spread (median absolute deviation)
62K
How far from its usual level
+11.9
Same report last year
60K
History used
1,477 days
2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M
the 31 Jan 2025 report24 earlier reportsnormal: 113K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Feb 2025

Eledon Pharmaceuticals had 1.2M shares sold short in the 14 Feb 2025 report, 22× the same report last year.

This period
1.2M (the 14 Feb 2025 report)
Normal report (median of 24 earlier)
118K
Typical spread (median absolute deviation)
71K
How far from its usual level
+10.0
Same report last year
53K
History used
1,491 days
2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M
the 14 Feb 2025 report24 earlier reportsnormal: 118K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Mar 2025

Eledon Pharmaceuticals had 1.3M shares sold short in the 28 Feb 2025 report, 34× the same report last year.

This period
1.3M (the 28 Feb 2025 report)
Normal report (median of 24 earlier)
124K
Typical spread (median absolute deviation)
80K
How far from its usual level
+10.3
Same report last year
39K
History used
1,505 days
2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M
the 28 Feb 2025 report24 earlier reportsnormal: 124K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Mar 2025

Eledon Pharmaceuticals had 1.4M shares sold short in the 14 Mar 2025 report, 38× the same report last year.

This period
1.4M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
136K
Typical spread (median absolute deviation)
93K
How far from its usual level
+9.0
Same report last year
36K
History used
1,519 days
2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M
the 14 Mar 2025 report24 earlier reportsnormal: 136K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Apr 2025

Eledon Pharmaceuticals had 1.5M shares sold short in the 31 Mar 2025 report, 14× the same report last year.

This period
1.5M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
157K
Typical spread (median absolute deviation)
115K
How far from its usual level
+7.7
Same report last year
107K
History used
1,536 days
2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M
the 31 Mar 2025 report24 earlier reportsnormal: 157K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Apr 2025

Eledon Pharmaceuticals had 1.8M shares sold short in the 15 Apr 2025 report, 56× the same report last year.

This period
1.8M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
181K
Typical spread (median absolute deviation)
148K
How far from its usual level
+7.2
Same report last year
31K
History used
1,551 days
2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M
the 15 Apr 2025 report24 earlier reportsnormal: 181K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 26 Nov 2025Short interest and volume change

    had 5.0M shares sold short in the 14 Nov 2025 report, 6.8× the same report last year.

    Same report last year: 731K; its normal report is 1.5M.

    See the evidence
    This period
    5.0M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    564K
    How far from its usual level
    +4.2
    Same report last year
    731K
    History used
    1,764 days
    2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M2025-09-30: 6.7M2025-10-15: 3.5M2025-10-31: 4.3M2025-11-14: 5.0M
    the 14 Nov 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 13 Nov 2025Short interest and volume change

    had 4.3M shares sold short in the 31 Oct 2025 report, 4.5× the same report last year.

    Same report last year: 961K; its normal report is 1.5M.

    See the evidence
    This period
    4.3M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    478K
    How far from its usual level
    +4.0
    Same report last year
    961K
    History used
    1,750 days
    2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M2025-09-30: 6.7M2025-10-15: 3.5M2025-10-31: 4.3M
    the 31 Oct 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 10 Oct 2025Short interest and volume change

    had 6.7M shares sold short in the 30 Sep 2025 report, 56× the same report last year.

    Same report last year: 119K; its normal report is 1.4M.

    See the evidence
    This period
    6.7M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    413K
    How far from its usual level
    +8.7
    Same report last year
    119K
    History used
    1,719 days
    2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M2025-09-30: 6.7M
    the 30 Sep 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Sep 2025Short interest and volume change

    had 5.4M shares sold short in the 15 Sep 2025 report, 65× the same report last year.

    Same report last year: 83K; its normal report is 1.3M.

    See the evidence
    This period
    5.4M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    428K
    How far from its usual level
    +6.5
    Same report last year
    83K
    History used
    1,704 days
    2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M
    the 15 Sep 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Sep 2025Short interest and volume change

    had 4.3M shares sold short in the 29 Aug 2025 report, 37× the same report last year.

    Same report last year: 118K; its normal report is 1.3M.

    See the evidence
    This period
    4.3M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    428K
    How far from its usual level
    +4.8
    Same report last year
    118K
    History used
    1,687 days
    2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M
    the 29 Aug 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 27 Aug 2025Short interest and volume change

    had 5.5M shares sold short in the 15 Aug 2025 report, 54× the same report last year.

    Same report last year: 101K; its normal report is 1.2M.

    See the evidence
    This period
    5.5M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    418K
    How far from its usual level
    +6.8
    Same report last year
    101K
    History used
    1,673 days
    2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M
    the 15 Aug 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 14 Aug 2025several at once

    saw 27 13F filers open a new position in the quarter ended 30 Jun 2025, 3.9× the same quarter last year, while it had 6.7M shares sold short in the 30 Sep 2025 report, 56× the same report last year. Two unrelated kinds of activity within 77 days.

    See the evidence (7 changes)

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    Eledon Pharmaceuticals had 3.1M shares sold short in the 15 Jul 2025 report, 24× the same report last year.

    This period
    3.1M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    387K
    How far from its usual level
    +3.5
    Same report last year
    129K
    History used
    1,642 days
    2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M
    the 15 Jul 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    Eledon Pharmaceuticals had 4.4M shares sold short in the 31 Jul 2025 report, 40× the same report last year.

    This period
    4.4M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    418K
    How far from its usual level
    +5.1
    Same report last year
    108K
    History used
    1,658 days
    2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M
    the 31 Jul 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

    Eledon Pharmaceuticals saw 27 13F filers open a new position in the quarter ended 30 Jun 2025, 3.9× the same quarter last year.

    This period
    27 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    4
    Typical spread (median absolute deviation)
    1.5
    How far from its usual level
    +7.7
    Same quarter last year
    7
    History used
    1,642 days
    2023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 342025-03-31: 182025-06-30: 27
    the quarter ended 30 Jun 20258 earlier quartersnormal: 4

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    Eledon Pharmaceuticals had 5.5M shares sold short in the 15 Aug 2025 report, 54× the same report last year.

    This period
    5.5M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    418K
    How far from its usual level
    +6.8
    Same report last year
    101K
    History used
    1,673 days
    2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M
    the 15 Aug 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Sep 2025

    Eledon Pharmaceuticals had 4.3M shares sold short in the 29 Aug 2025 report, 37× the same report last year.

    This period
    4.3M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    428K
    How far from its usual level
    +4.8
    Same report last year
    118K
    History used
    1,687 days
    2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M
    the 29 Aug 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Sep 2025

    Eledon Pharmaceuticals had 5.4M shares sold short in the 15 Sep 2025 report, 65× the same report last year.

    This period
    5.4M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    428K
    How far from its usual level
    +6.5
    Same report last year
    83K
    History used
    1,704 days
    2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M
    the 15 Sep 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Oct 2025

    Eledon Pharmaceuticals had 6.7M shares sold short in the 30 Sep 2025 report, 56× the same report last year.

    This period
    6.7M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    413K
    How far from its usual level
    +8.7
    Same report last year
    119K
    History used
    1,719 days
    2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M2025-08-15: 5.5M2025-08-29: 4.3M2025-09-15: 5.4M2025-09-30: 6.7M
    the 30 Sep 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  8. 14 Aug 2025Institutional holdings change

    saw 27 13F filers open a new position in the quarter ended 30 Jun 2025, 3.9× the same quarter last year.

    Same quarter last year: 7; its normal quarter is 4.

    See the evidence
    This period
    27 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    4
    Typical spread (median absolute deviation)
    1.5
    How far from its usual level
    +7.7
    Same quarter last year
    7
    History used
    1,642 days
    2023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 342025-03-31: 182025-06-30: 27
    the quarter ended 30 Jun 20258 earlier quartersnormal: 4

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  9. 14 Aug 2025Filings record

    Earlier financial statements can no longer be relied on

  10. 12 Aug 2025Short interest and volume change

    had 4.4M shares sold short in the 31 Jul 2025 report, 40× the same report last year.

    Same report last year: 108K; its normal report is 1.2M.

    See the evidence
    This period
    4.4M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    418K
    How far from its usual level
    +5.1
    Same report last year
    108K
    History used
    1,658 days
    2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M2025-07-31: 4.4M
    the 31 Jul 2025 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 25 Jul 2025Short interest and volume change

    had 3.1M shares sold short in the 15 Jul 2025 report, 24× the same report last year.

    Same report last year: 129K; its normal report is 1.1M.

    See the evidence
    This period
    3.1M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    387K
    How far from its usual level
    +3.5
    Same report last year
    129K
    History used
    1,642 days
    2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M2025-04-30: 1.8M2025-05-15: 1.6M2025-05-30: 1.5M2025-06-13: 1.3M2025-06-30: 3.3M2025-07-15: 3.1M
    the 15 Jul 2025 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 26 Apr 2025Short interest and volume change

    had 1.8M shares sold short in the 15 Apr 2025 report, 56× the same report last year.

    Same report last year: 31K; its normal report is 181K.

    See the evidence
    This period
    1.8M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    181K
    Typical spread (median absolute deviation)
    148K
    How far from its usual level
    +7.2
    Same report last year
    31K
    History used
    1,551 days
    2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M
    the 15 Apr 2025 report24 earlier reportsnormal: 181K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 10 Apr 2025Short interest and volume change

    had 1.5M shares sold short in the 31 Mar 2025 report, 14× the same report last year.

    Same report last year: 107K; its normal report is 157K.

    See the evidence
    This period
    1.5M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    157K
    Typical spread (median absolute deviation)
    115K
    How far from its usual level
    +7.7
    Same report last year
    107K
    History used
    1,536 days
    2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M
    the 31 Mar 2025 report24 earlier reportsnormal: 157K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 7 Apr 2025Filings record

    Changed its auditor

  15. 26 Mar 2025Short interest and volume change

    had 1.4M shares sold short in the 14 Mar 2025 report, 38× the same report last year.

    Same report last year: 36K; its normal report is 136K.

    See the evidence
    This period
    1.4M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    136K
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +9.0
    Same report last year
    36K
    History used
    1,519 days
    2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M
    the 14 Mar 2025 report24 earlier reportsnormal: 136K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 12 Mar 2025Short interest and volume change

    had 1.3M shares sold short in the 28 Feb 2025 report, 34× the same report last year.

    Same report last year: 39K; its normal report is 124K.

    See the evidence
    This period
    1.3M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    124K
    Typical spread (median absolute deviation)
    80K
    How far from its usual level
    +10.3
    Same report last year
    39K
    History used
    1,505 days
    2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M
    the 28 Feb 2025 report24 earlier reportsnormal: 124K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 27 Feb 2025Short interest and volume change

    had 1.2M shares sold short in the 14 Feb 2025 report, 22× the same report last year.

    Same report last year: 53K; its normal report is 118K.

    See the evidence
    This period
    1.2M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    118K
    Typical spread (median absolute deviation)
    71K
    How far from its usual level
    +10.0
    Same report last year
    53K
    History used
    1,491 days
    2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M
    the 14 Feb 2025 report24 earlier reportsnormal: 118K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 18 Feb 2025several at once

    saw 34 13F filers open a new position in the quarter ended 31 Dec 2024, 8.5× the same quarter last year, while it had 1.4M shares sold short in the 14 Mar 2025 report, 38× the same report last year. Two unrelated kinds of activity within 91 days.

    See the evidence (8 changes)

    Short interest and volume: Short interest spike became public on 28 Jan 2025

    Eledon Pharmaceuticals had 1.0M shares sold short in the 15 Jan 2025 report, 14× the same report last year.

    This period
    1.0M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    107K
    Typical spread (median absolute deviation)
    57K
    How far from its usual level
    +10.6
    Same report last year
    71K
    History used
    1,461 days
    2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M
    the 15 Jan 2025 report24 earlier reportsnormal: 107K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Feb 2025

    Eledon Pharmaceuticals saw 34 13F filers open a new position in the quarter ended 31 Dec 2024, 8.5× the same quarter last year.

    This period
    34 (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    3.5
    Typical spread (median absolute deviation)
    1
    How far from its usual level
    +10.2
    Same quarter last year
    4
    History used
    1,461 days
    2022-12-31: 12023-03-31: 72023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 34
    the quarter ended 31 Dec 20248 earlier quartersnormal: 3.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 12 Feb 2025

    Eledon Pharmaceuticals had 1.2M shares sold short in the 31 Jan 2025 report, 20× the same report last year.

    This period
    1.2M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    113K
    Typical spread (median absolute deviation)
    62K
    How far from its usual level
    +11.9
    Same report last year
    60K
    History used
    1,477 days
    2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M
    the 31 Jan 2025 report24 earlier reportsnormal: 113K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 27 Feb 2025

    Eledon Pharmaceuticals had 1.2M shares sold short in the 14 Feb 2025 report, 22× the same report last year.

    This period
    1.2M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    118K
    Typical spread (median absolute deviation)
    71K
    How far from its usual level
    +10.0
    Same report last year
    53K
    History used
    1,491 days
    2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M
    the 14 Feb 2025 report24 earlier reportsnormal: 118K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Mar 2025

    Eledon Pharmaceuticals had 1.3M shares sold short in the 28 Feb 2025 report, 34× the same report last year.

    This period
    1.3M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    124K
    Typical spread (median absolute deviation)
    80K
    How far from its usual level
    +10.3
    Same report last year
    39K
    History used
    1,505 days
    2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M
    the 28 Feb 2025 report24 earlier reportsnormal: 124K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Mar 2025

    Eledon Pharmaceuticals had 1.4M shares sold short in the 14 Mar 2025 report, 38× the same report last year.

    This period
    1.4M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    136K
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +9.0
    Same report last year
    36K
    History used
    1,519 days
    2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M
    the 14 Mar 2025 report24 earlier reportsnormal: 136K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Apr 2025

    Eledon Pharmaceuticals had 1.5M shares sold short in the 31 Mar 2025 report, 14× the same report last year.

    This period
    1.5M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    157K
    Typical spread (median absolute deviation)
    115K
    How far from its usual level
    +7.7
    Same report last year
    107K
    History used
    1,536 days
    2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M
    the 31 Mar 2025 report24 earlier reportsnormal: 157K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Apr 2025

    Eledon Pharmaceuticals had 1.8M shares sold short in the 15 Apr 2025 report, 56× the same report last year.

    This period
    1.8M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    181K
    Typical spread (median absolute deviation)
    148K
    How far from its usual level
    +7.2
    Same report last year
    31K
    History used
    1,551 days
    2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M2025-02-14: 1.2M2025-02-28: 1.3M2025-03-14: 1.4M2025-03-31: 1.5M2025-04-15: 1.8M
    the 15 Apr 2025 report24 earlier reportsnormal: 181K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  19. 14 Feb 2025Institutional holdings change

    saw 34 13F filers open a new position in the quarter ended 31 Dec 2024, 8.5× the same quarter last year.

    Same quarter last year: 4; its normal quarter is 3.5.

    See the evidence
    This period
    34 (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    3.5
    Typical spread (median absolute deviation)
    1
    How far from its usual level
    +10.2
    Same quarter last year
    4
    History used
    1,461 days
    2022-12-31: 12023-03-31: 72023-06-30: 42023-09-30: 32023-12-31: 42024-03-31: 32024-06-30: 72024-09-30: 22024-12-31: 34
    the quarter ended 31 Dec 20248 earlier quartersnormal: 3.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  20. 12 Feb 2025Short interest and volume change

    had 1.2M shares sold short in the 31 Jan 2025 report, 20× the same report last year.

    Same report last year: 60K; its normal report is 113K.

    See the evidence
    This period
    1.2M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    113K
    Typical spread (median absolute deviation)
    62K
    How far from its usual level
    +11.9
    Same report last year
    60K
    History used
    1,477 days
    2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M2025-01-31: 1.2M
    the 31 Jan 2025 report24 earlier reportsnormal: 113K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 28 Jan 2025Short interest and volume change

    had 1.0M shares sold short in the 15 Jan 2025 report, 14× the same report last year.

    Same report last year: 71K; its normal report is 107K.

    See the evidence
    This period
    1.0M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    107K
    Typical spread (median absolute deviation)
    57K
    How far from its usual level
    +10.6
    Same report last year
    71K
    History used
    1,461 days
    2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M2025-01-15: 1.0M
    the 15 Jan 2025 report24 earlier reportsnormal: 107K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 14 Jan 2025Short interest and volume change

    had 1.2M shares sold short in the 31 Dec 2024 report, 24× the same report last year.

    Same report last year: 52K; its normal report is 104K.

    See the evidence
    This period
    1.2M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    104K
    Typical spread (median absolute deviation)
    52K
    How far from its usual level
    +14.9
    Same report last year
    52K
    History used
    1,446 days
    2023-12-29: 52K2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K2024-12-31: 1.2M
    the 31 Dec 2024 report24 earlier reportsnormal: 104K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 25 Dec 2024Short interest and volume change

    had 898K shares sold short in the 13 Dec 2024 report, 14× the same report last year.

    Same report last year: 65K; its normal report is 92K.

    See the evidence
    This period
    898K (the 13 Dec 2024 report)
    Normal report (median of 24 earlier)
    92K
    Typical spread (median absolute deviation)
    40K
    How far from its usual level
    +13.7
    Same report last year
    65K
    History used
    1,428 days
    2023-12-15: 65K2023-12-29: 52K2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K2024-12-13: 898K
    the 13 Dec 2024 report24 earlier reportsnormal: 92K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 20 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 20 Dec 2024Filings record

    Director or officer change

  26. 11 Dec 2024Short interest and volume change

    had 687K shares sold short in the 29 Nov 2024 report, 26× the same report last year.

    Same report last year: 26K; its normal report is 77K.

    See the evidence
    This period
    687K (the 29 Nov 2024 report)
    Normal report (median of 24 earlier)
    77K
    Typical spread (median absolute deviation)
    39K
    How far from its usual level
    +10.4
    Same report last year
    26K
    History used
    1,414 days
    2023-11-30: 26K2023-12-15: 65K2023-12-29: 52K2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K2024-11-29: 687K
    the 29 Nov 2024 report24 earlier reportsnormal: 77K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 27 Nov 2024Short interest and volume change

    had 731K shares sold short in the 15 Nov 2024 report, 11× the same report last year.

    Same report last year: 66K; its normal report is 69K.

    See the evidence
    This period
    731K (the 15 Nov 2024 report)
    Normal report (median of 24 earlier)
    69K
    Typical spread (median absolute deviation)
    33K
    How far from its usual level
    +13.3
    Same report last year
    66K
    History used
    1,400 days
    2023-11-15: 66K2023-11-30: 26K2023-12-15: 65K2023-12-29: 52K2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K2024-11-15: 731K
    the 15 Nov 2024 report24 earlier reportsnormal: 69K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 13 Nov 2024Short interest and volume change

    had 961K shares sold short in the 31 Oct 2024 report, 18× the same report last year.

    Same report last year: 52K; its normal report is 66K.

    See the evidence
    This period
    961K (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    66K
    Typical spread (median absolute deviation)
    30K
    How far from its usual level
    +17.9
    Same report last year
    52K
    History used
    1,385 days
    2023-10-31: 52K2023-11-15: 66K2023-11-30: 26K2023-12-15: 65K2023-12-29: 52K2024-01-12: 71K2024-01-31: 60K2024-02-15: 53K2024-02-29: 39K2024-03-15: 36K2024-03-28: 107K2024-04-15: 31K2024-04-30: 35K2024-05-15: 191K2024-05-31: 49K2024-06-14: 52K2024-06-28: 171K2024-07-15: 129K2024-07-31: 108K2024-08-15: 101K2024-08-30: 118K2024-09-13: 83K2024-09-30: 119K2024-10-15: 143K2024-10-31: 961K
    the 31 Oct 2024 report24 earlier reportsnormal: 66K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 14 Aug 2024Filings record

    Earlier financial statements can no longer be relied on

  30. 14 Aug 2024Filings record

    Report will be filed late

  31. 12 Jul 2024Filings record

    Changed its auditor

  32. 10 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 10 Jul 2024Filings record

    Director or officer change

  34. 22 May 2024Filings record

    Private placement of securities (Form D)

  35. 14 May 2024Insiders record

    BVF INC/IL (ten percent owner) and 9 other(s) bought 1,927,937 shares of ELDN (dated 13 May 2024)

  36. 2 Oct 2023Filings record

    Director or officer change

  37. 20 Sep 2023Filings record

    Director or officer change

  38. 13 Sep 2023Filings record

    Director or officer change

  39. 21 Jun 2023Filings record

    Director or officer change

  40. 22 May 2023Filings record

    Private placement of securities (Form D)

Showing the newest 40 of 92 entries; narrow the window or the kind of data to see older ones.

Not listed: 111 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001404281
Ticker
ELDN
Domain
eledon.com
Hq location
CA|IRVINE|92612 (1 unverified)
Name
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
  • SEC Form 13F institutional holdings216 data points31 Dec 2020 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)150 records7 Jan 2016 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)693 data points31 Dec 2011 to 10 Nov 2026
  • SEC Form 4 insider transactions22 records, 64 data points15 Mar 2016 to 13 May 2024
  • FINRA short interest (twice monthly)417 data points15 Jan 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2956 data points5 Jan 2021 to 20 Nov 2026